Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Tobacco Alternative Gums - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.
The global market for Tobacco Alternative Gums was estimated at US$2.9 Billion in 2023, and is projected to reach US$4.3 Billion by 2030, growing at a CAGR of 6.0% from 2023 to 2030.
Key Market Trends & Drivers:
- Rising Health Awareness and Anti-Smoking Campaigns
- Increasing Regulatory Restrictions on Tobacco Products
- Innovations in Flavor and Product Formulations
- Growing Popularity of Nicotine Replacement Therapies (NRTs)
- Expansion in Retail Distribution Channels
- Demand for Over-the-Counter Smoking Cessation Aids
- Technological Advancements in Gum Manufacturing
- Influence of Social Media and Digital Marketing
- Introduction of Sugar-Free and Low-Calorie Options
- Growing Adoption in Emerging Markets
Key Insights:
- Market Growth: Understand the significant growth trajectory of the 2 mg Nicotine Content Gums segment, which is expected to reach US$3.5 Billion by 2030 with a CAGR of a 6.4%. The 4 mg Nicotine Content Gums segment is also set to grow at 4.5% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $764.4 Million in 2023, and China, forecasted to grow at an impressive 9.7% CAGR to reach $986.9 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Key Questions Answered:
- How is the Global Tobacco Alternative Gums Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Alchem International Pvt. Ltd., Cambrex Corp., Cipla Inc., and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 41 Featured):
- Alchem International Pvt. Ltd.
- Cambrex Corp.
- Cipla Inc.
- Dr. Reddys Laboratories Ltd.
- GlaxoSmithKline
- ITC Ltd.
- Johnson & Johnson
- Novartis
- Perrigo Co.
- Reynolds American Incorporated
- Takeda Pharmaceutical Co. Ltd.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 275 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value (USD) in 2023 | $2.9 Billion |
| Forecasted Market Value (USD) by 2030 | $4.3 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
For more information about this report visit https://www.researchandmarkets.com/r/4qsw9c
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
